Clinical Trials Browser

Phase 2 × Neurofibroma × Temozolomide × Clear all

NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

Phase 2 Completed

9 enrolled 9 charts

Neurofibroma, Neurofibromatosis 1